Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Placeholder Photo
Martin Gleave, MD
CMO, SUSTAINED THERAPEUTICS
Sustained Therapeutics
Bothell, Washington, United States
Matt Gline
CHIEF EXECUTIVE OFFICER, ROIVANT SCIENCES
Biopharma Dealmaking in Uncertain Times
Gregory Glover, MD,JD
PRINCIPAL, PHARMACEUTICAL LAW GROUP PC
Driving the Rare Disease Innovation Pipeline to Bring New Products to Market
Washington, United States
Richard Godfrey
BUSINESS DEVELOPMENT LICENSING, PARTNERING AND COLLABORATIONS, QBIOTICS
QBiotics Group
Zelanna Goldberg
CHIEF MEDICAL OFFICER, REPLICATE BIOSCIENCE
Emerging RNA Therapy Platforms: The Next Generation Genetic Medicines
San Diego, California, United States
Manijeh Goldberg, PhD
PRESIDENT & CEO, PRIVO TECHNOLOGIES INC.
Privo Technologies Inc,
Peabody, Massachusetts, United States
Jennifer Goldsack
CEO, DIGITAL MEDICINE SOCIETY (DIME)
Advancing Digital Health Innovation in the Gray Space of Evolving FDA Regulations: What to Expect in 2023 and Beyond
Ariane Gomes
CHIEF SCIENTIFIC OFFICER, BASEIMMUNE
Baseimmune
London, United Kingdom
Jennifer Good
CO-FOUNDER, PRESIDENT & CEO, TREVI THERAPEUTICS
Trevi Therapeutics, Inc.
New Haven, Connecticut, United States
Wyatt Gotbetter
SENIOR VICE PRESIDENT AND WORLDWIDE HEAD, ACCESS CONSULTING, PAREXEL
Tailored Regulatory and Access Strategies to Drive Cell and Gene Therapy Innovation and Value for Clinical Developers